Northern Ireland Cancer Trials Centre

Trials open to recruitment - February 2013

Click on study titles in blue tolink to the relevant CancerHelp UK trial summary.

GeDDIS - A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas

Updated 26 February 2013